BamSEC and AlphaSense Join Forces
Learn More

BioXcel Therapeutics Inc. – Articles of Incorporation

NASDAQ: BTAI    
Share price (7/6/26): $1.10    
Market cap (7/6/26): $34.0 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as Amended of BioXcel Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Amended and Restated Certificate of Incorporation, as Amended of BioXcel Therapeutics, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3
from SC 13D 18 pages Repurchase Agreement
12/34/56
EX-3.1
from 10-Q 10 pages ​ Amended and Restated Certificate of Incorporation of BioXcel Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Amended and Restated Certificate of Incorporation of BioXcel Therapeutics, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 17 pages BioXcel Therapeutics, Inc. Incorporated Under the Laws of the State of Delaware By-Laws March 12, 2018 Amended and Restated By-Laws of BioXcel Therapeutics, Inc. Preamble
12/34/56
EX-3.1
from 8-K 9 pages Amended and Restated Certificate of Incorporation of BioXcel Therapeutics, Inc
12/34/56
EX-3.4
from S-1 16 pages BioXcel Therapeutics, Inc. Incorporated Under the Laws of the State of Delaware Amended and Restated By-Laws [ , 2018] Amended and Restated By-Laws of BioXcel Therapeutics, Inc. Preamble
12/34/56
EX-3.3
from S-1 9 pages Bylaws of BioXcel Therapeutics, Inc
12/34/56
EX-3.2
from S-1 8 pages Amended and Restated Certificate of Incorporation of BioXcel Therapeutics, Inc
12/34/56
EX-3.1
from S-1 4 pages Delaware the First State
12/34/56
EX-3.3
from DRS 9 pages Bylaws of BioXcel Therapeutics, Inc
12/34/56
EX-3.1
from DRS 4 pages Delaware the First State
12/34/56